High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis [PDF]
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2018 We performed a cross-sectional study in 123 Chinese multiple sclerosis patients residing in Hong Kong to evaluate their anti-John Cunningham virus status using STRATIFY JCV DxSelect assays.
Alexander Lau +10 more
doaj +6 more sources
John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis [PDF]
DiseasesProgressive Multifocal Leukoencephalopathy (PML) is a possibly fatal demyelinating disease and John Cunningham Polyomavirus (JCPyV) is believed to cause this condition.
Dimitra S. Mouliou
doaj +4 more sources
Conversion and reversion of anti‐John Cunningham virus antibody serostatus: A prospective study [PDF]
Brain and Behavior, 2019 Introduction Determination of antibodies against the John Cunningham virus (JCV) is an important tool for risk stratification in Natalizumab‐treated multiple sclerosis (MS) patients.
Michael Auer +7 more
doaj +5 more sources
A Case of John Cunningham Virus Induced Rhombencephalitis after Rituximab Therapy for Idiopathic Thrombocytopenic Purpura [PDF]
Case Reports in Infectious Diseases, 2021 Background. John Cunningham virus (JCV) is known to cause progressive multifocal leukoencephalopathy (PML) in immuno-compromised patients due to lytic infection of oligodendrocytes and astrocytes. Rarely, it may also present as granule cell neuronopathy (
Silpita Katragadda +4 more
doaj +6 more sources
COS-7-based model: methodological approach to study John Cunningham virus replication cycle [PDF]
Virology Journal, 2018 John Cunningham virus (JCV) is a human neurotropic polyomavirus whose replication in the Central Nervous System (SNC) induces the fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML).
C. Prezioso +6 more
doaj +6 more sources
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level [PDF]
Therapeutics and Clinical Risk Management, 2014 Roberta Lanzillo,1 Raffaele Liuzzi,2 Luca Vallefuoco,3 Marcello Moccia,1 Luca Amato,1 Giovanni Vacca,1 Veria Vacchiano,1 Giuseppe Portella,3 Vincenzo Brescia Morra1 1Neurological Sciences Department, Federico II University, 2Institute of Biostructure and
Lanzillo R +8 more
doaj +8 more sources
BK and JC polyomavirus co-infection resulting in polyomavirus nephropathy and progressive multifocal leukoencephalopathy at the same time, a case report [PDF]
Brazilian Journal of Infectious DiseasesJohn Cunningham Virus (JCV) and BK Virus (BKV) are the most extensively studied Human Polyomaviruses (HPyVs), primarily associated with Progressive Multifocal Leukoencephalopathy (PML) and BKV Nephropathy (BKVN), respectively.
Sébastien Briol +5 more
doaj +2 more sources
Progressive multifocal leukoencephalopathy successfully treated with mefloquine and literature review [PDF]
Encephalitis, 2021 Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection due to reactivation of John Cunningham virus (JCV). The diagnosis depends on evidence from clinical, imaging, and virologic studies.
Sungjoon Yoon +3 more
doaj +1 more source
Rates of John Cunningham virus seroconversion greatly reduced in natalizumab‐treated patients during COVID‐19‐related lockdowns [PDF]
European Journal of NeurologyChris Dwyer, Tomas Kalincik
exaly +2 more sources
Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica [PDF]
Epidemiology and Health, 2018 Sonia Patricia Castedo Paz +2 more
exaly +2 more sources